The award of a new patent to Adial Pharmaceuticals is significant as it enhances the company's intellectual property portfolio, which is crucial for protecting its innovations and maintaining a competitive edge in the market. This could lead to new revenue streams through licensing or direct application of the patented technology in its products, positively impacting its stock price in the short term.